John Napoli, PHD

NPI: 1225004997
Total Payments
$7,335
2024 Payments
$1,563
Companies
21
Transactions
479
Medicare Patients
454
Medicare Billing
$54,067

Payment Breakdown by Category

Food & Beverage$7,169 (97.7%)
Education$165.39 (2.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,169 476 97.7%
Education $165.39 3 2.3%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $1,913 91 $0 (2024)
Sunovion Pharmaceuticals Inc. $815.32 76 $0 (2022)
ABBVIE INC. $782.83 80 $0 (2024)
Otsuka America Pharmaceutical, Inc. $601.48 38 $0 (2024)
Allergan, Inc. $479.78 47 $0 (2020)
Teva Pharmaceuticals USA, Inc. $422.48 21 $0 (2023)
ITI, Inc. $394.88 26 $0 (2023)
Lundbeck LLC $359.11 17 $0 (2024)
Neurocrine Biosciences, Inc. $340.51 17 $0 (2024)
Vanda Pharmaceuticals Inc. $299.46 16 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,563 103 Otsuka America Pharmaceutical, Inc. ($272.87)
2023 $1,380 80 Alkermes, Inc. ($348.12)
2022 $944.47 57 Alkermes, Inc. ($336.36)
2021 $955.00 65 AbbVie Inc. ($212.24)
2020 $755.40 55 Sunovion Pharmaceuticals Inc. ($247.37)
2019 $398.92 34 Alkermes, Inc. ($181.86)
2018 $662.16 44 Alkermes, Inc. ($293.53)
2017 $675.92 41 Alkermes, Inc. ($281.28)

All Payment Transactions

479 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/23/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $13.94 General
Category: PSYCHIATRY
12/18/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $12.44 General
Category: Neuropsychiatry
12/17/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $19.58 General
Category: PSYCHIATRY
12/11/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $29.00 General
Category: CNS
12/09/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $10.74 General
Category: PSYCHIATRY
12/09/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.39 General
Category: NEUROSCIENCE
12/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $12.82 General
Category: PSYCHIATRY
12/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.49 General
Category: PSYCHIATRY
12/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $1.16 General
Category: PSYCHIATRY
12/03/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $22.15 General
Category: Psychiatry/Psychology
12/02/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.39 General
Category: NEUROSCIENCE
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.53 General
Category: NEUROSCIENCE
11/13/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $25.10 General
Category: PSYCHIATRY
11/13/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $10.14 General
Category: PSYCHIATRY
11/12/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $110.99 General
Category: Psychiatry/Psychology
11/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $9.99 General
Category: PSYCHIATRY
11/08/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $10.05 General
Category: PSYCHIATRY
11/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $12.63 General
Category: Neuropsychiatry
11/05/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $13.51 General
Category: Psychiatry/Psychology
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.94 General
Category: NEUROSCIENCE
10/23/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $30.89 General
Category: CNS
10/17/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $22.64 General
Category: PSYCHIATRY
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.33 General
Category: NEUROSCIENCE
10/11/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.84 General
Category: PSYCHIATRY
10/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.09 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 53 175 $16,338 $10,096
2022 3 100 344 $36,454 $18,005
2021 4 131 334 $45,438 $15,118
2020 3 170 331 $44,524 $10,848
Total Patients
454
Total Services
1,184
Medicare Billing
$54,067
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 31 138 $12,878 $8,651 67.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 22 37 $3,460 $1,445 41.8%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 45 160 $15,895 $10,509 66.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 34 127 $15,240 $5,191 34.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 21 57 $5,319 $2,306 43.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 42 137 $16,440 $6,457 39.3%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 20 50 $7,368 $2,833 38.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 32 54 $6,480 $2,440 37.7%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 12 12 $3,000 $1,902 63.4%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 25 81 $12,150 $1,486 12.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 51 99 $11,880 $3,898 32.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 66 91 $12,483 $3,323 26.6%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 32 104 $15,560 $1,845 11.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 21 37 $4,602 $1,783 38.7%

About John Napoli, PHD

John Napoli, PHD is a Psychiatry healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225004997.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Napoli, PHD has received a total of $7,335 in payments from pharmaceutical and medical device companies, with $1,563 received in 2024. These payments were reported across 479 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,169).

As a Medicare-enrolled provider, Napoli has provided services to 454 Medicare beneficiaries, totaling 1,184 services with total Medicare billing of $54,067. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Buffalo, NY
  • Active Since 02/23/2006
  • Last Updated 01/11/2012
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1225004997

Products in Payments

  • ARISTADA (Drug) $1,327
  • VRAYLAR (Drug) $1,258
  • LATUDA (Drug) $815.32
  • REXULTI (Drug) $701.98
  • CAPLYTA (Drug) $661.53
  • Aristada 441 mg (Drug) $554.93
  • INGREZZA (Drug) $340.51
  • AUSTEDO (Drug) $273.38
  • FANAPT (Drug) $196.92
  • TRINTELLIX (Drug) $161.61
  • COBENFY (Drug) $146.65
  • Azstarys (Drug) $109.06
  • HETLIOZ (Drug) $102.54
  • Auvelity (Drug) $94.34
  • ABILIFY MAINTENA (Drug) $83.17
  • SPRAVATO (Drug) $69.37
  • Sunosi (Drug) $62.10
  • Austedo XR (Drug) $49.18
  • BRINTELLIX (Drug) $43.55
  • APLENZIN (Drug) $32.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Buffalo